Literature DB >> 25707335

Fluorescence in situ hybridization detects increased sperm aneuploidy in men with recurrent pregnancy loss.

Ranjith Ramasamy1, Jason M Scovell2, Jason R Kovac1, Peter J Cook2, Dolores J Lamb3, Larry I Lipshultz4.   

Abstract

OBJECTIVE: To investigate, in men presenting with recurrent pregnancy loss (RPL), the prevalence of sperm autosome and sex chromosome aneuploidy.
DESIGN: Retrospective study.
SETTING: Male infertility clinic. PATIENT(S): A total of 140 men with RPL provided semen samples, and five normozoospermic controls provided 140 semen samples for comparison. Recurrent pregnancy loss, documented in the female partners, was defined as a prior miscarriage and/or recurrent IVF/intracytoplasmic sperm injection failure. INTERVENTION(S): Fluorescence in situ hybridization (FISH) was used to detect numerical abnormalities in sex chromosomes (X, Y) and autosomes (13, 18, 21) in ejaculated sperm. MAIN OUTCOME MEASURE(S): Sperm aneuploidy in men with RPL and normozoospermic controls. RESULT(S): Men with RPL had a greater percentage of sperm aneuploidy within the sex chromosomes and chromosomes 18 and 13/21 (1.04% vs. 0.38%; 0.18% vs. 0.03%; 0.26% vs. 0.08%). In total, 40% of men with normal sperm density and motility had abnormal sperm aneuploidy in all the chromosomes analyzed. Men with abnormal sperm density and motility had a higher proportion of sperm sex chromosome aneuploidy than men with normal density/motility (62% vs. 45%). Men with normal strict morphology (>4%) had lower rates of sex chromosome and sperm aneuploidy than men with abnormal strict morphology (28% vs. 57%). There was no association between sperm DNA fragmentation and sperm aneuploidy. CONCLUSION(S): Men with RPL have increased sperm aneuploidy compared with controls. A total of 40% of men with RPL and normal sperm density/motility had abnormal sperm aneuploidy. Men with oligoasthenozoospermia and abnormal strict morphology had a greater percentage of sperm aneuploidy compared with men with normal semen parameters.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FISH; Male infertility; aneuploidy; genetics

Mesh:

Year:  2015        PMID: 25707335      PMCID: PMC4385482          DOI: 10.1016/j.fertnstert.2015.01.029

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  14 in total

1.  Increased incidence of disomic sperm nuclei in a 47,XYY male assessed by fluorescent in situ hybridization (FISH).

Authors:  J Blanco; C Rubio; C Simon; J Egozcue; F Vidal
Journal:  Hum Genet       Date:  1997-03       Impact factor: 4.132

Review 2.  Assisted reproductive technologies and the risk of birth defects--a systematic review.

Authors:  Michèle Hansen; Carol Bower; Elizabeth Milne; Nicholas de Klerk; Jennifer J Kurinczuk
Journal:  Hum Reprod       Date:  2004-11-26       Impact factor: 6.918

Review 3.  Risk during pregnancy and birth after assisted reproductive technologies: an integral view of the problem.

Authors:  Michael Ludwig
Journal:  Semin Reprod Med       Date:  2005-11       Impact factor: 1.303

4.  A meta-analysis of controlled studies comparing major malformation rates in IVF and ICSI infants with naturally conceived children.

Authors:  Alfred A Rimm; Alyce C Katayama; Mireya Diaz; K Paul Katayama
Journal:  J Assist Reprod Genet       Date:  2004-12       Impact factor: 3.412

5.  Increased chromosome X, Y, and 18 nondisjunction in sperm from infertile patients that were identified as normal by strict morphology: implication for intracytoplasmic sperm injection.

Authors:  H M Ryu; W W Lin; D J Lamb; W Chuang; L I Lipshultz; F Z Bischoff
Journal:  Fertil Steril       Date:  2001-11       Impact factor: 7.329

6.  The high frequency of sperm aneuploidy in klinefelter patients and in nonobstructive azoospermia is due to meiotic errors in euploid spermatocytes.

Authors:  François Vialard; Marc Bailly; Habib Bouazzi; Martine Albert; Jean Christophe Pont; Vanda Mendes; Marianne Bergere; Denise Molina Gomes; Philippe de Mazancourt; Jacqueline Selva
Journal:  J Androl       Date:  2012-04-05

7.  Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth.

Authors:  Anjani Chandra; Gladys M Martinez; William D Mosher; Joyce C Abma; Jo Jones
Journal:  Vital Health Stat 23       Date:  2005-12

8.  [Chromosomal survey of 1001 subfertile males: incidence and clinical features of males with chromosomal anomalies].

Authors:  T Matsuda; Y Horii; K Ogura; M Nonomura; K Okada; O Yoshida
Journal:  Hinyokika Kiyo       Date:  1992-07

9.  Sperm selection methods for intracytoplasmic sperm injection (ICSI) in andrological patients.

Authors:  R Sanchez; T Stalf; O Khanaga; H Turley; H Gips; W B Schill
Journal:  J Assist Reprod Genet       Date:  1996-03       Impact factor: 3.412

10.  Preoperative screening for genetic abnormalities in men with nonobstructive azoospermia before testicular sperm extraction.

Authors:  G B Rucker; A Mielnik; P King; M Goldstein; P N Schlegel
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

View more
  28 in total

Review 1.  Paternal factors contributing to embryo quality.

Authors:  Stacy Colaco; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2018-09-11       Impact factor: 3.412

2.  Next-generation sequencing analysis of each blastomere in good-quality embryos: insights into the origins and mechanisms of embryonic aneuploidy in cleavage-stage embryos.

Authors:  Qiuwen Shi; Ying Qiu; Changlong Xu; Hua Yang; Chunyuan Li; Nina Li; Yumei Gao; Caiyun Yu
Journal:  J Assist Reprod Genet       Date:  2020-05-22       Impact factor: 3.412

Review 3.  Genetic and epigenetic variations associated with idiopathic recurrent pregnancy loss.

Authors:  Luis Alejandro Arias-Sosa; Iván Darío Acosta; Elkin Lucena-Quevedo; Harold Moreno-Ortiz; Clara Esteban-Pérez; Maribel Forero-Castro
Journal:  J Assist Reprod Genet       Date:  2018-01-09       Impact factor: 3.412

4.  Genetic abnormalities and pregnancy loss.

Authors:  Nathan R Blue; Jessica M Page; Robert M Silver
Journal:  Semin Perinatol       Date:  2018-12-19       Impact factor: 3.300

5.  Reasons that should prompt a referral to a reproductive urologist: guidelines for the gynecologist and reproductive endocrinologist.

Authors:  Nicholas J Farber; Vinayak K Madhusoodanan; Sabrina A Gerkowicz; Premal Patel; Ranjith Ramasamy
Journal:  Gynecol Pelvic Med       Date:  2019-10-23

Review 6.  Male infertility: establishing sperm aneuploidy thresholds in the laboratory.

Authors:  Elena García-Mengual; Juan Carlos Triviño; Alba Sáez-Cuevas; Juan Bataller; Miguel Ruíz-Jorro; Xavier Vendrell
Journal:  J Assist Reprod Genet       Date:  2019-01-02       Impact factor: 3.412

7.  Semen quality and pregnancy loss in a contemporary cohort of couples recruited before conception: data from the Longitudinal Investigation of Fertility and the Environment (LIFE) Study.

Authors:  Michael L Eisenberg; Katherine J Sapra; Sung Duk Kim; Zhen Chen; Germaine M Buck Louis
Journal:  Fertil Steril       Date:  2017-08-30       Impact factor: 7.329

Review 8.  Genetics of Male Infertility.

Authors:  Filipe Tenorio Lira Neto; Phil Vu Bach; Bobby Baback Najari; Philip Shihua Li; Marc Goldstein
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

Review 9.  Genetic counseling for men with recurrent pregnancy loss or recurrent implantation failure due to abnormal sperm chromosomal aneuploidy.

Authors:  Taylor P Kohn; Jaden R Kohn; Sandra Darilek; Ranjith Ramasamy; Larry Lipshultz
Journal:  J Assist Reprod Genet       Date:  2016-03-28       Impact factor: 3.412

10.  Centriolar defects, centrin 1 alterations, and FISH studies in human spermatozoa of a male partner of a couple that produces aneuploid embryos in natural and artificial fertilization.

Authors:  Elena Moretti; Daria Noto; Raffaella Guazzo; Andrea Menchiari; Giuseppe Belmonte; Giulia Collodel
Journal:  J Assist Reprod Genet       Date:  2021-02-22       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.